Mortality From Respiratory Syncytial Virus in Children Under 2 Years of Age: A Prospective Community Cohort Study in

Eric A F Simões1,2, Vibhawari Dani3, Varsha Potdar4

  • 1Department of Paediatric Infectious Diseases, University of Colorado School of Medicine and Children's Hospital Colorado Aurora, Colorado, USA.

Insights

Respiratory syncytial virus (RSV) causes many infant deaths, particularly in communities with limited healthcare access. This study highlights that most RSV lower respiratory tract infection (LRTI) deaths occur outside hospitals, emphasizing the need for targeted prevention strategies.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Respiratory syncytial virus (RSV) is a primary cause of infant mortality from lower respiratory tract infections (LRTIs).
  • Limited data exist on infant deaths attributed to RSV within community settings.

Purpose of the Study:

  • To investigate the burden and mortality associated with RSV-associated LRTIs in infants.
  • To determine the proportion of RSV LRTI deaths occurring in community versus hospital settings.

Main Methods:

  • Active surveillance was conducted in children under 2 years across 93 villages, 5 primary health centers, and 3 hospitals.
  • Nasopharyngeal swabs were collected for RSV detection in severe/very severe LRTIs and all deaths.
  • Case fatality ratios and mortality rates were calculated for RSV LRTI cases.

Main Results:

  • RSV was detected in a significant proportion of severe and very severe LRTIs, with a high fatality rate (94%) among confirmed cases.
  • The majority of RSV LRTI deaths (14 out of 15) occurred in the community, not in hospitals.
  • Adjusted RSV LRTI mortality rates were substantial, contributing significantly to overall infant LRTI deaths and postneonatal mortality.

Conclusions:

  • Community deaths significantly outweigh hospital deaths from RSV-associated LRTIs.
  • Prevention strategies for RSV should prioritize populations with restricted access to healthcare.
  • Understanding community-based mortality is crucial for effective RSV control in infants.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
449
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
428
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
239
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
401
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K